Nasdaq is closing the exits, not the entrance.

This week, Nasdaq's new $25 million minimum on China-based IPOs goes operative. Everyone is watching the front door. The more consequential change is happening at the back, where Nasdaq is quietly dismantling the survival kit that kept sub-scale companies listed long after the market stopped caring.

For two years the conversation about Asian companies and Nasdaq has been about getting on. Can we qualify, what is the float, how big does the raise need to be. That conversation now has a hard number attached to it for China-based issuers, namely the $25 million in gross IPO proceeds that the SEC approved in May and that takes effect this month. It is a clean, quotable rule, and it has absorbed almost all of the attention.

I want to point somewhere quieter. While the market argued about the entrance, Nasdaq spent the first half of 2026 rebuilding the rules for staying listed. Those rules will outlast the headline, and they matter more to the companies we actually work with, because most of our work happens after the bell, not before it.

The escape hatch is closing

Here is the mechanism that is disappearing. For years, a listed company drifting below the minimum bid price could buy itself room with a reverse split: collapse ten shares into one, lift the quoted price back above a dollar, reset the clock. It was rarely a sign of health. It was a way to keep the listing alive while the business was repaired, or, less charitably, while it was not.

Through 2025 and into 2026, Nasdaq closed that hatch. A company that does a reverse split and then falls out of bid-price compliance again inside a year now gets a delisting determination, not a fresh cure period. And if the corporate action used to fix the price knocks the company below another standard, such as the public-shares minimum, there is no grace window for the new deficiency either. The financial-engineering route to survival is being sealed off, one rule at a time.

A listing used to be a finish line you could coast past. Nasdaq is turning it back into a standard you have to hold, every quarter, in public.

A floor with no cure period

The bigger structural change is the proposed continued-listing standard built on market value. Nasdaq has asked the SEC for the power to require a minimum $5 million market value of listed securities to stay on, and, crucially, to suspend a company immediately once it sits below that line for 30 consecutive trading days, with no 180-day cure window and limited appeal.

Read the detail and you see the intent. The current framework assumes a deficient company is basically sound and simply needs time. The proposed framework assumes the opposite, namely that a company the market values at under $5 million has already told you something, and the exchange should stop carrying it. The burden of proof flips. For the first time in a long while, staying listed on Nasdaq will demand that the market keep voting for you, continuously, not just once on listing day.

Layer on the related proposal to delist faster after an SEC trading suspension, and the direction is unmistakable. Nasdaq is done being the patient landlord of companies that the market has already left.

Why this sorts in our favour

It would be easy to read all of this as the US market closing to Asian growth companies. That is the wrong read. What is closing is a particular kind of listing, namely the under-scaled, under-capitalised one that was only ever viable because the rules were forgiving on the way down. The door for a properly built company is exactly where it was.

This is the corridor we have always worked in. We invest post-SEC, at the final private round, into companies that can clear a real bar, and we stay involved through the post-listing year that most regional advisors treat as someone else's problem. Our case studies are not deals we took public and walked away from. They are companies under active post-listing maintenance, namely stock management, investor relations, and the unglamorous quarterly discipline that keeps a company comfortably above every line Nasdaq is now drawing.

When the exchange removes the escape hatches, the value of doing the work properly the first time goes up. A company that listed at scale, with a genuine float and a market value that sits well clear of $5 million, never has to think about reverse splits or 30-day suspension clocks. The new rules are punishing for the company that treated the listing as the finish line. They are almost invisible to the company that treated it as the starting line.

What this means for us

For founders weighing a US listing from Kuala Lumpur, Hong Kong, or Singapore, the lesson of 2026 is simple to say and hard to do: list at scale or do not list. The window for the small, hopeful, lightly capitalised Nasdaq debut is closing from both ends at once, namely a higher entry floor and a stricter survival test. That is not a reason to stay home. It is a reason to prepare properly, raise enough, and build the governance that holds.

For investors, the same shift is a quiet endorsement of how we structure capital. Our post-IPO instruments run on 12 to 36 month horizons against companies we expect to keep clearing the bar, not companies hoping a reverse split buys another year. A market that enforces survival is a market where disciplined, operator-led positions are worth more, not less. We have spent this cycle saying discipline first, narrative second. Nasdaq has just written that preference into its rulebook.

The entrance got a number. The exits got sealed. The companies in between, the ones built to stay, are exactly the ones we want to back. Strike it with purpose. Strike it with pride.